Katherine Vega Stultz - President and CEO of Ocelot Bio

Send us Fan MailIn this episode of Life Science Success, my guest is Katherine Vega Stultz.  Katherine is the President and CEO of Ocelot Bio, a clinical stage company focused on developing innovative therapeutics to significantly improve outcomes for patients with end-stage liver disease.   In this episode of Life Science Success my guest is Katherine Vega Stultz and we touch upon a number of topics, including the non-linear path of career growth, the importance of being a generalist in a specialized industry, and the challenges and opportunities facing Ocelot Bio, a private venture-backed company that is focused on liver disease. Stultz talks about the importance of team collaboration, transparency, and communication, and how her experiences have helped her develop a continuous improvement mindset. She also discusses her passion for tackling complex problems that impact people's lives and how she is excited to be in a position of leadership that advocates for diversity and talent. Non-linear path of career growth Importance of being a generalist in a specialized industry Challenges and opportunities facing Ocelot Bio Importance of team collaboration, transparency, and communication Continuous improvement mindset Passion for tackling complex problems that impact people's lives Advocacy for diversity and talent in leadership